Clinical Trials for Those Requiring Repeat Peptide Receptor Radionuclide Therapy

Find clinical trials for those requiring repeat peptide receptor radionuclide therapy. Discover research opportunities and treatment options in your area.

1 Active Trial Found

Showing 1 trial on this page

Page 1 of 1

Trial of Lu-177 DOTATATE (Lutathera®) in Unlicensed Indications

NCT ID: NCT06121271

This clinical trial is studying a treatment called Lu-177 DOTATATE (also known as Lutathera) for patients with certain types of neuroendocrine tumors that are difficult to remove or have spread to ...

Not yet recruiting

Phase: PHASE2 Type: interventional

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Prostate Cancer View clinical trials → Healthy View clinical trials →

Search All Trials Browse All Conditions